COPD-related bronchiectasis; independent impact on disease course and outcomes

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 6, 2014, Pages 605-614

  Gatheral, Timothy ^a   Kumar, Neelam ^a   Sansom, Ben ^a   Lai, Dilys ^b   Nair, Arjun ^c   Vlahos, Ioannis ^c   Baker, Emma H ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Airway; Computerised tomography; Emphysema; Infection

Indexed keywords

AGED; ARTICLE; ATYPICAL MYCOBACTERIUM; BRONCHIAL WALL THICKENING; BRONCHIECTASIS; BRONCHUS DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ICD-10; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERSISTENT INFECTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; RESIDUAL VOLUME; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; BRONCHOGRAPHY; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; ISOLATION AND PURIFICATION; LUNG EMPHYSEMA; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRONCHIECTASIS; BRONCHOGRAPHY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NONTUBERCULOUS MYCOBACTERIA; PSEUDOMONAS AERUGINOSA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPUTUM; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84910612435     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.922174     Document Type: Article

References (20)

1. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65 Suppl 1:i1-58.
2. Bafadhel M, Umar I, Gupta S, Raj JV, Vara DD, Entwisle JJ, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest 2011; 140(3):634-642.
3. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55(8):635-642.
4. Roche N, Kouassi B, Rabbat A, Mounedji A, Lorut C, Huchon G. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration Inter Rev Thora Dis 2007; 74(1):19-25.
5. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122.
6. Martinez-Garcia MA, Soler-Cataluna JJ, Donat Sanz Y, Catalan Serra P, Agramunt Lerma M, Ballestin Vicente J, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011; 140(5):1130-1137.
7. Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2007; 176(12):1215-1221.
8. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170(4):400-407.
9. Garcia-Vidal C, Almagro P, Romani V, Rodriguez-Carballeira M, Cuchi E, Canales L, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Euro Respir J 2009; 34(5):1072-1078.
10. Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comp Assist Tomogr 1982; 6(3):437-444.
11. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4):347-365.
12. Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi JC, Burnand B, et al. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care 2007; 45(12):1210-1215.
13. Cole P. The damaging role of bacteria in chronic lung infection. J Antimicrob Chemo 1997; 40 Suppl A:5-10.
14. Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380(9842): 660-667.
15. Murray MP, Govan JR, Doherty CJ, Simpson AJ, Wilkinson TS, Chalmers JD, et al. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2011; 183(4):491-499.
16. Wilson R, Welte T, Polverino E, De Soyza A, Greville H, O'Donnell A, et al. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. Euro Respir J 2013; 41(5):1107-1115.
17. Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Data System Rev 2012; 3:CD008328.
18. Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JAD, Criner GJ, et al. Azithromycin for Prevention of Exacerbations of COPD. New Engl J Med 2011; 365(8):689-698.
19. Martinez-Garcia MA, de la Rosa Carrillo D, Soler-Cataluna JJ, Donat-Sanz Y, Serra PC, Lerma MA, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187(8):823-831.
20. Tulek B, Kivrak AS, Ozbek S, Kanat F, Suerdem M. Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J 2013; 20(2):91-96.